NO152297C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt salt av 1,3-bis(2-karboksykromon-5-yloksy)-propan-2-ol med et antihistamin - Google Patents

Analogifremgangsmaate for fremstilling av et terapeutisk aktivt salt av 1,3-bis(2-karboksykromon-5-yloksy)-propan-2-ol med et antihistamin

Info

Publication number
NO152297C
NO152297C NO780935A NO780935A NO152297C NO 152297 C NO152297 C NO 152297C NO 780935 A NO780935 A NO 780935A NO 780935 A NO780935 A NO 780935A NO 152297 C NO152297 C NO 152297C
Authority
NO
Norway
Prior art keywords
carboxychromon
antihistamine
yloxy
propan
bis
Prior art date
Application number
NO780935A
Other languages
English (en)
Other versions
NO780935L (no
NO152297B (no
Inventor
Joachim Augstein
Roger Edward Colling Altounyan
Thomas Brian Lee
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NO780935L publication Critical patent/NO780935L/no
Publication of NO152297B publication Critical patent/NO152297B/no
Publication of NO152297C publication Critical patent/NO152297C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO780935A 1977-03-17 1978-03-16 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt salt av 1,3-bis(2-karboksykromon-5-yloksy)-propan-2-ol med et antihistamin NO152297C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11390/77A GB1582362A (en) 1977-03-17 1977-03-17 Cromoglycic acid salts and compositions

Publications (3)

Publication Number Publication Date
NO780935L NO780935L (no) 1978-09-19
NO152297B NO152297B (no) 1985-05-28
NO152297C true NO152297C (no) 1985-09-04

Family

ID=9985349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO780935A NO152297C (no) 1977-03-17 1978-03-16 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt salt av 1,3-bis(2-karboksykromon-5-yloksy)-propan-2-ol med et antihistamin

Country Status (18)

Country Link
JP (1) JPS53115823A (no)
AU (1) AU516337B2 (no)
BE (1) BE864837A (no)
CA (1) CA1113862A (no)
CH (1) CH628517A5 (no)
DE (1) DE2810974A1 (no)
DK (1) DK113378A (no)
FI (1) FI780782A (no)
FR (1) FR2383937A1 (no)
GB (1) GB1582362A (no)
IE (1) IE46581B1 (no)
IL (1) IL54264A (no)
LU (1) LU79253A1 (no)
NL (1) NL7802869A (no)
NO (1) NO152297C (no)
NZ (1) NZ186712A (no)
SE (1) SE444939B (no)
ZA (1) ZA781520B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2535258C2 (de) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk Inhalierbares Medikament in Pelletform

Also Published As

Publication number Publication date
FR2383937B1 (no) 1982-07-23
NO780935L (no) 1978-09-19
IE46581B1 (en) 1983-07-27
AU3427278A (en) 1979-09-20
NZ186712A (en) 1979-12-11
SE7803069L (sv) 1978-09-18
CH628517A5 (en) 1982-03-15
NL7802869A (nl) 1978-09-19
JPS53115823A (en) 1978-10-09
ZA781520B (en) 1979-04-25
IL54264A (en) 1984-01-31
BE864837A (fr) 1978-09-13
LU79253A1 (fr) 1978-10-17
DE2810974A1 (de) 1978-09-21
FI780782A (fi) 1978-09-18
DE2810974C2 (no) 1988-07-21
FR2383937A1 (fr) 1978-10-13
IE780530L (en) 1978-09-17
IL54264A0 (en) 1978-06-15
DK113378A (da) 1978-09-18
NO152297B (no) 1985-05-28
GB1582362A (en) 1981-01-07
AU516337B2 (en) 1981-05-28
CA1113862A (en) 1981-12-08
SE444939B (sv) 1986-05-20

Similar Documents

Publication Publication Date Title
NO782127L (no) Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO156752C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO154013C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater.
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
NO152297C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt salt av 1,3-bis(2-karboksykromon-5-yloksy)-propan-2-ol med et antihistamin
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO149471C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO145656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater
NO151324C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-tieno(2,3-c)-piperidin-forbindelser
NO149209C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(3-(3,4,5-trimetoksyfenoksy)-2-hydroksypropyl))-4-aryl-piperazin-derivater
NO146744C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme (omega-aminoalkoksy)-dibenzyl derivater